Turnstone Biologics Corporation (TSBX) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Turnstone Biologics Corp (TSBX)

Cancer immunotherapy development is proceeding within a secure jurisdiction supported by stable international cooperation. Turnstone Biologics (TSBX) relies on lymphocyte selection to combat solid tumors while striving for pricing leadership. However, the costs of personalized manufacturing and testing uncertainties create risks. The cash structure on this GURU.Markets platform chart is fixed at 0.02, confirming current financial stability.

TSBX - Cadangan dhuwit perusahaan turnstonebio.com ing rentang 21.02.2024 - 24.08.2025

Rincian analitis perusahaan Turnstone Biologics

Pambiji fundamental perusahaan:Turnstone Biologics Corp. TSBX
Produk merek Turnstone Biologics

This indicator reflects the dynamics of liquid assets, allowing for an assessment of capital management efficiency and the rate of cash burn. By analyzing the history of cash volume changes, an investor determines the stability of the company's financial reserve. The metric measures the balance between resource accumulation and operational expenditure. For Turnstone Biologics (TSBX), this is critical due to the high cost of cell therapy trials. Monitoring cash balances ensures uninterrupted biomaterial logistics under high-risk conditions.

Pesaing Turnstone Biologics (TSBX)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|INTS (Intensity Therapeutics, Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan SNSE|Dana dhuwit perusahaan TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Kineta KA|NexImmune Corporation - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan